Table III.
Treatment group | Inflammation score |
Number of mice | ||||
0 | 1 | 2 | 3 | 4 | ||
DSS 1.5 cycles | 0 (0)a | 0 (0) | 2 (20) | 2 (20) | 6 (60) | 10 |
DSS 2.5 cycles | 0 (0) | 0 (0) | 0 (0) | 5 (50) | 5 (50) | 10 |
DSS + American ginseng 2.5 cycles | 0 (0) | 0 (0) | 2 (28.6) | 3 (42.8) | 2 (28.6) | 7 |
DSS 3.5 cycles | 0 (0) | 0 (0) | 0 (0) | 5 (35.7) | 9 (64.3) | 14 |
DSS + American ginseng 3.5 cyclesb | 0 (0) | 0 (0) | 5 (62.5) | 3 (37.5) | 0 (0) | 8 |
Treatment group | Ulceration score | Number of mice | ||||
0 | 1 | 2 | 3 | 4 | ||
DSS 1.5 cycles | 0 (0)a | 1 (10) | 6 (60) | 2 (20) | 1 (10) | 10 |
DSS 2.5 cycles | 0 (0) | 0 (0) | 4 (40) | 5 (50) | 1 (10) | 10 |
DSS + American ginseng 2.5 cycles | 0 (0) | 1 (14.3) | 6 (85.7) | 0 (0) | 0 (0) | 7 |
DSS 3.5 cycles | 0 (0) | 2 (14.3) | 3 (21.4) | 5 (35.7) | 4 (28.6) | 14 |
DSS + American ginseng 3.5 cyclesc | 0 (0) | 5 (62.5) | 3 (37.5) | 0 (0) | 0 (0) | 8 |
Number in brackets indicates percentage of mice.
The P-value associated with the observed chi-square value, under the hypothesis of no differences between the two groups, is 0.0054 for the inflammation score.
The P-value associated with the observed chi-square value, under the hypothesis of no differences between the two groups, is 0.0088 for the ulceration score.